Achieve Life Sciences, Inc. (QUIT)
NASDAQ: QUIT · Real-Time Price · USD
6.29
-0.16 (-2.48%)
At close: Nov 12, 2026, 4:00 PM EST
6.29
0.00 (0.00%)
After-hours: Nov 12, 2026, 4:15 PM EST

Achieve Life Sciences Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Achieve Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $14.58. The average 1-year stock price forecast is 131.80% higher than the current stock price, while the lowest is $10 (+58.98%) and the highest is $21 (+233.86%).

Price Target: $14.58 (+131.80%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$10$14.58$13$21
Change+58.98%+131.80%+106.68%+233.86%

Analyst Ratings

The average analyst rating for Achieve Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy778998
Buy223333
Hold000000
Sell000000
Strong Sell000000
Total9911121211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JonesTrading
JonesTrading
Buy
Reiterates
$10
BuyReiterates$10+58.98%Nov 12, 2026
Maxim Group
Maxim Group
Buy
Maintains
$10
BuyMaintains$10+58.98%Nov 12, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$13
BuyMaintains$13+106.68%Nov 11, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$12
BuyReiterates$12+90.78%Nov 11, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$13
BuyMaintains$13+106.68%Oct 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
32.28M
EPS This Year
-1.38
from -1.25
EPS Next Year
-0.69
from -1.38
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-33.09M-40.80M-27.25M-39.07M-54.88M-71.58M
Net Income
-33.15M-42.35M-29.82M-39.83M-54.65M-125.98M
EPS
-----1.25-1.38
Free Cash Flow
-----49.47M-56.50M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-0.63
Avg-1.38
Low-1.86

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-